A pragmatic cluster randomised controlled trial of a Diabetes REcall And Management system: the DREAM trial

<p>Abstract</p> <p>Background</p> <p>Following the introduction of a computerised diabetes register in part of the northeast of England, care initially improved but then plateaued. We therefore enhanced the existing diabetes register to address these problems. The aim o...

Full description

Bibliographic Details
Main Authors: Grimshaw Jeremy M, Hawthorne Gillian C, Vanoli Alessandra, Steen Ian N, Speed Chris, Whitty Paula M, Eccles Martin P, Wood Linda J, McDowell David
Format: Article
Language:English
Published: BMC 2007-02-01
Series:Implementation Science
Online Access:http://www.implementationscience.com/content/2/1/6
_version_ 1818806825932292096
author Grimshaw Jeremy M
Hawthorne Gillian C
Vanoli Alessandra
Steen Ian N
Speed Chris
Whitty Paula M
Eccles Martin P
Wood Linda J
McDowell David
author_facet Grimshaw Jeremy M
Hawthorne Gillian C
Vanoli Alessandra
Steen Ian N
Speed Chris
Whitty Paula M
Eccles Martin P
Wood Linda J
McDowell David
author_sort Grimshaw Jeremy M
collection DOAJ
description <p>Abstract</p> <p>Background</p> <p>Following the introduction of a computerised diabetes register in part of the northeast of England, care initially improved but then plateaued. We therefore enhanced the existing diabetes register to address these problems. The aim of the trial was to evaluate the effectiveness and efficiency of an area wide 'extended,' computerised diabetes register incorporating a full structured recall and management system, including individualised patient management prompts to primary care clinicians based on locally-adapted, evidence-based guidelines.</p> <p>Methods</p> <p>The study design was a pragmatic, cluster randomised controlled trial, with the general practice as the unit of randomisation. Set in 58 general practices in three Primary Care Trusts in the northeast of England, the study outcomes were the clinical process and outcome variables held on the diabetes register, patient-reported outcomes, and service and patient costs. The effect of the intervention was estimated using generalised linear models with an appropriate error structure. To allow for the clustering of patients within practices, population averaged models were estimated using generalized estimating equations.</p> <p>Results</p> <p>Patients in intervention practices were more likely to have at least one diabetes appointment recorded (OR 2.00, 95% CI 1.02, 3.91), to have a recording of a foot check (OR 1.87, 95% CI 1.09, 3.21), have a recording of receiving dietary advice (OR 2.77, 95% CI 1.22, 6.29), and have a recording of blood pressure (BP) (OR 2.14, 95% CI 1.06, 4.36). There was no difference in mean HbA1c or BP levels, but the mean cholesterol level in patients from intervention practices was significantly lower (-0.15 mmol/l, 95% CI -0.25, -0.06). There were no differences in patient-reported outcomes or in patient-reported use of drugs, or uptake of health services. The average cost per patient was not significantly different between the intervention and control groups. Costs incurred in administering the system at the register and in general practice were in addition to these.</p> <p>Conclusion</p> <p>This study has shown benefits from an area-wide, computerised diabetes register incorporating a full structured recall and individualised patient management system. However, these benefits were achieved at a cost. In future, these costs may fall as electronic data exchange becomes a reliable reality. </p> <p><b>Trial registration</b>: International Standard Randomised Controlled Trial Number (ISRCTN) Register, ISRCTN32042030.</p>
first_indexed 2024-12-18T19:15:56Z
format Article
id doaj.art-8f8cf7b1c888453b9c95e87b35a8d98a
institution Directory Open Access Journal
issn 1748-5908
language English
last_indexed 2024-12-18T19:15:56Z
publishDate 2007-02-01
publisher BMC
record_format Article
series Implementation Science
spelling doaj.art-8f8cf7b1c888453b9c95e87b35a8d98a2022-12-21T20:56:08ZengBMCImplementation Science1748-59082007-02-0121610.1186/1748-5908-2-6A pragmatic cluster randomised controlled trial of a Diabetes REcall And Management system: the DREAM trialGrimshaw Jeremy MHawthorne Gillian CVanoli AlessandraSteen Ian NSpeed ChrisWhitty Paula MEccles Martin PWood Linda JMcDowell David<p>Abstract</p> <p>Background</p> <p>Following the introduction of a computerised diabetes register in part of the northeast of England, care initially improved but then plateaued. We therefore enhanced the existing diabetes register to address these problems. The aim of the trial was to evaluate the effectiveness and efficiency of an area wide 'extended,' computerised diabetes register incorporating a full structured recall and management system, including individualised patient management prompts to primary care clinicians based on locally-adapted, evidence-based guidelines.</p> <p>Methods</p> <p>The study design was a pragmatic, cluster randomised controlled trial, with the general practice as the unit of randomisation. Set in 58 general practices in three Primary Care Trusts in the northeast of England, the study outcomes were the clinical process and outcome variables held on the diabetes register, patient-reported outcomes, and service and patient costs. The effect of the intervention was estimated using generalised linear models with an appropriate error structure. To allow for the clustering of patients within practices, population averaged models were estimated using generalized estimating equations.</p> <p>Results</p> <p>Patients in intervention practices were more likely to have at least one diabetes appointment recorded (OR 2.00, 95% CI 1.02, 3.91), to have a recording of a foot check (OR 1.87, 95% CI 1.09, 3.21), have a recording of receiving dietary advice (OR 2.77, 95% CI 1.22, 6.29), and have a recording of blood pressure (BP) (OR 2.14, 95% CI 1.06, 4.36). There was no difference in mean HbA1c or BP levels, but the mean cholesterol level in patients from intervention practices was significantly lower (-0.15 mmol/l, 95% CI -0.25, -0.06). There were no differences in patient-reported outcomes or in patient-reported use of drugs, or uptake of health services. The average cost per patient was not significantly different between the intervention and control groups. Costs incurred in administering the system at the register and in general practice were in addition to these.</p> <p>Conclusion</p> <p>This study has shown benefits from an area-wide, computerised diabetes register incorporating a full structured recall and individualised patient management system. However, these benefits were achieved at a cost. In future, these costs may fall as electronic data exchange becomes a reliable reality. </p> <p><b>Trial registration</b>: International Standard Randomised Controlled Trial Number (ISRCTN) Register, ISRCTN32042030.</p>http://www.implementationscience.com/content/2/1/6
spellingShingle Grimshaw Jeremy M
Hawthorne Gillian C
Vanoli Alessandra
Steen Ian N
Speed Chris
Whitty Paula M
Eccles Martin P
Wood Linda J
McDowell David
A pragmatic cluster randomised controlled trial of a Diabetes REcall And Management system: the DREAM trial
Implementation Science
title A pragmatic cluster randomised controlled trial of a Diabetes REcall And Management system: the DREAM trial
title_full A pragmatic cluster randomised controlled trial of a Diabetes REcall And Management system: the DREAM trial
title_fullStr A pragmatic cluster randomised controlled trial of a Diabetes REcall And Management system: the DREAM trial
title_full_unstemmed A pragmatic cluster randomised controlled trial of a Diabetes REcall And Management system: the DREAM trial
title_short A pragmatic cluster randomised controlled trial of a Diabetes REcall And Management system: the DREAM trial
title_sort pragmatic cluster randomised controlled trial of a diabetes recall and management system the dream trial
url http://www.implementationscience.com/content/2/1/6
work_keys_str_mv AT grimshawjeremym apragmaticclusterrandomisedcontrolledtrialofadiabetesrecallandmanagementsystemthedreamtrial
AT hawthornegillianc apragmaticclusterrandomisedcontrolledtrialofadiabetesrecallandmanagementsystemthedreamtrial
AT vanolialessandra apragmaticclusterrandomisedcontrolledtrialofadiabetesrecallandmanagementsystemthedreamtrial
AT steeniann apragmaticclusterrandomisedcontrolledtrialofadiabetesrecallandmanagementsystemthedreamtrial
AT speedchris apragmaticclusterrandomisedcontrolledtrialofadiabetesrecallandmanagementsystemthedreamtrial
AT whittypaulam apragmaticclusterrandomisedcontrolledtrialofadiabetesrecallandmanagementsystemthedreamtrial
AT ecclesmartinp apragmaticclusterrandomisedcontrolledtrialofadiabetesrecallandmanagementsystemthedreamtrial
AT woodlindaj apragmaticclusterrandomisedcontrolledtrialofadiabetesrecallandmanagementsystemthedreamtrial
AT mcdowelldavid apragmaticclusterrandomisedcontrolledtrialofadiabetesrecallandmanagementsystemthedreamtrial
AT grimshawjeremym pragmaticclusterrandomisedcontrolledtrialofadiabetesrecallandmanagementsystemthedreamtrial
AT hawthornegillianc pragmaticclusterrandomisedcontrolledtrialofadiabetesrecallandmanagementsystemthedreamtrial
AT vanolialessandra pragmaticclusterrandomisedcontrolledtrialofadiabetesrecallandmanagementsystemthedreamtrial
AT steeniann pragmaticclusterrandomisedcontrolledtrialofadiabetesrecallandmanagementsystemthedreamtrial
AT speedchris pragmaticclusterrandomisedcontrolledtrialofadiabetesrecallandmanagementsystemthedreamtrial
AT whittypaulam pragmaticclusterrandomisedcontrolledtrialofadiabetesrecallandmanagementsystemthedreamtrial
AT ecclesmartinp pragmaticclusterrandomisedcontrolledtrialofadiabetesrecallandmanagementsystemthedreamtrial
AT woodlindaj pragmaticclusterrandomisedcontrolledtrialofadiabetesrecallandmanagementsystemthedreamtrial
AT mcdowelldavid pragmaticclusterrandomisedcontrolledtrialofadiabetesrecallandmanagementsystemthedreamtrial